ELI LILLY ~ IDENTITY
When Eli Lilly pharmaceutical launched a clinical trial for a new alzheimer's drug, they sought a way to promote the trial to patients and their caregivers. The goal was to give them a kit that would help guide them the process as the condition progressed. The solution was a "memory box" that would initially house informational materials, and later serve as a place for personal items to be stored that would help the patient retain their identity.
